Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response
Jie Zhou(Cleveland Clinic), Brian P. Hobbs(Tellabs (Canada)), Peng Wei(Creighton University), H. Amy Xia(Xiangyang Central Hospital), Xun Jiang
Cited by 8
Related Papers
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Use of historical control data for assessing treatment effects in clinical trials
|Pharmaceutical Statistics|2013|505
Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases
|American Journal of Epidemiology|2017|218